United States Antimony (UAMY)
(Delayed Data from AMEX)
$0.24 USD
-0.01 (-2.88%)
Updated Apr 25, 2024 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for United States Antimony Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 9 | 11 | 8 | 5 | 8 |
Cost Of Goods | 12 | 9 | 7 | 5 | 9 |
Gross Profit | -3 | 2 | 1 | 0 | -1 |
Selling & Adminstrative & Depr. & Amort Expenses | 4 | 2 | 2 | 4 | 3 |
Income After Depreciation & Amortization | -7 | 0 | -1 | -3 | -4 |
Non-Operating Income | 1 | 0 | 1 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -6 | 0 | 0 | -3 | -4 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -6 | 0 | 0 | -3 | -4 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -6 | 0 | 0 | -3 | -4 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -6 | 1 | 0 | -2 | -3 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -7 | 0 | -1 | -3 | -4 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 107.55 | 106.29 | NA | 72.51 | 69.01 |
Diluted EPS Before Non-Recurring Items | -0.06 | 0.00 | NA | -0.05 | -0.05 |
Diluted Net EPS (GAAP) | -0.06 | 0.00 | 0.00 | -0.05 | -0.05 |
Fiscal Year end for United States Antimony Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 1.67 | 2.31 | 2.50 | 2.21 |
Cost Of Goods | NA | 3.71 | 3.37 | 2.21 | 2.75 |
Gross Profit | NA | -2.04 | -1.06 | 0.30 | -0.54 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1.68 | 0.76 | 0.81 | 0.48 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -3.72 | -1.82 | -0.51 | -1.02 |
Non-Operating Income | NA | 0.24 | 0.18 | 0.17 | 0.13 |
Interest Expense | NA | 0.07 | 0.00 | 0.00 | -0.07 |
Pretax Income | NA | -3.56 | -1.64 | -0.34 | -0.81 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -3.56 | -1.65 | -0.34 | -0.81 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -3.56 | -1.65 | -0.34 | -0.81 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 107.58 | 107.65 | 107.65 | 107.26 |
Diluted EPS Before Non-Recurring Items | NA | -0.03 | -0.02 | 0.00 | -0.01 |
Diluted Net EPS (GAAP) | NA | -0.03 | -0.02 | 0.00 | -0.01 |